- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05572307
Peripheral Blood Single Cell Sequencing Analysis of POD and CPSP in Elderly Patients After Total Knee Arthroplasty
October 5, 2022 updated by: Xuzhou Central Hospital
Peripheral Blood Single Cell Sequencing Analysis of Postoperative Delirium (POD) and Chronic Postsurgical Pain (CPSP) in Elderly Patients After Total Knee Arthroplasty
Single-celled sequencing for evaluating differences in gene expression patterns in different cell types of the dynamics of a means of this research as a starting point, to study the postoperative delirium and chronic pain at the cellular level changes the contents of a cell, reveal its occurrence and development of the role of gene regulation, find targets and biomarkers, and to provide new ideas for its pathogenesis, To provide theoretical basis support for its prevention, clinical diagnosis and treatment.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
The aim of this study was to investigate leukocyte heterogeneity in patients undergoing total knee arthroplasty with POD, paired non-POD patients, and cognitively normal healthy subjects by single cell sequencing, and to investigate leukocyte heterogeneity in patients with chronic pain and patients with pain relief after surgery through postoperative pain follow-up.
Moreover, multi-omics single cell technology is used to analyze various cellular contents in a single cell simultaneously, which can capture molecular footprints with higher resolution.
Comprehensive analysis of multiple omics datasets reveals the relationships between cellular patterns, establishes complex regulatory networks, and provides a holistic view of cellular state.
From a single cell level analysis of POD and occurred in patients with chronic pain in patients with the characteristics of the white blood cells, looking for the peripheral immune system in the pathogenesis of the POD and the potential role of chronic pain occurs, may provide POD pathogenesis and chronic pain occurred an important visual Angle, may also help to provide POD biomarkers and therapeutic targets, To provide a possible solution for the prevention and treatment of postoperative delirium and postoperative chronic pain.
Study Type
Observational
Enrollment (Anticipated)
10
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years to 80 years (OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing elective total knee replacement.
Description
Inclusion Criteria:
- Age ≥65 years old, regardless of gender.
- total knee arthroplasty for the first time.
- The ASA classification is I-Ⅲ.
Exclusion Criteria:
- severe neurological or psychiatric disorders
- drug and alcohol abuse
- patients on antidepressants
- failure and decompensation of vital organs
- chronic pain from previous surgery or trauma
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
POD group
According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group
|
|
non-POD group
According to the occurrence of postoperative delirium, the patients were divided into POD group and non-POD group
|
|
CPSP group
Patients were divided into CPSP group and non-CPSP group according to the occurrence of postoperative chronic pain
|
|
non-CSP group
Patients were divided into CPSP group and non-CPSP group according to the occurrence of postoperative chronic pain
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference of single cell sequencing before and after surgery
Time Frame: 1 day before surgery,1 day after surgery
|
Leukocytes were isolated from peripheral blood and then sorted for subsequent single-cell sequencing analysis.
Unbiased, high-throughput and high-resolution transcriptome analysis of single cells can reveal the gene structure and gene expression status of single cells, reflect the heterogeneity between cells, classify and analyze them, and carry out personalized research
|
1 day before surgery,1 day after surgery
|
|
3-minute Diagnostic Interview for CAM (3D-CAM)
Time Frame: Consecutive 7 days after the surgery
|
Postoperative delirium was assessed by 3-minute Diagnostic Interview for confusion assessment method (CAM).
|
Consecutive 7 days after the surgery
|
|
Visual analogue scale(VAS)
Time Frame: 3 months after the surgery
|
A moving scale measuring about 10cm in length was used, with 10 scales on one side and "0" and "10" ends, respectively, with 0 indicating no pain and 10 indicating the most severe pain that could not be endured.
|
3 months after the surgery
|
|
Short form McGill pain questionnaire(SF-MPQ)
Time Frame: 3 months after the surgery
|
SF-MPQ is composed of sensory and emotional descriptors of pain, current pain intensity and visual analogue scale.
|
3 months after the surgery
|
|
Leeds Assessment of Neuropathic Symptoms and Signs(LANSS)
Time Frame: 3 months after the surgery
|
Make the needle perpendicular to the patient's skin, and apply different pressure on the skin to determine whether the patient has touch-induced pain.
|
3 months after the surgery
|
|
Pain catastrophizing scale(PCS)
Time Frame: 3 months after the surgery
|
PCS is defined as a belief system, a coping strategy and an evaluation process when experiencing and feeling pain.
|
3 months after the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Junli Cao, Doctor, Jiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University
- Study Chair: Daqing Ma, Doctor, Imperial College London, Chelsea and Westminster Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
October 30, 2022
Primary Completion (ANTICIPATED)
October 30, 2023
Study Completion (ANTICIPATED)
December 31, 2023
Study Registration Dates
First Submitted
September 29, 2022
First Submitted That Met QC Criteria
October 5, 2022
First Posted (ACTUAL)
October 7, 2022
Study Record Updates
Last Update Posted (ACTUAL)
October 7, 2022
Last Update Submitted That Met QC Criteria
October 5, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XuzhouCH20221010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Delirium
-
Sengkang General HospitalRecruitingDelirium and Post-operative Cognitive Dysfunction (POCD) | Delirium, Postoperative | Delirium - PostoperativeSingapore
-
Wonkwang University HospitalCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityActive, not recruitingPostoperative Delirium (POD)China
-
Qin ZhangNational Natural Science Foundation of ChinaRecruiting
-
Qin ZhangNational Natural Science Foundation of ChinaRecruitingDelirium, PostoperativeChina
-
Hao LiCompleted
-
Chinese PLA General HospitalXiangya Hospital of Central South University; The Affiliated Nanjing Drum Tower... and other collaboratorsCompletedPostoperative Delirium (POD)China
-
Riverside University Health System Medical CenterNot yet recruitingPostoperative Delirium (POD) | Norepinephrine | Ephedrine
-
University Hospital, Basel, SwitzerlandInnosuisse - Swiss Innovation AgencyCompletedPostoperative Delirium (POD)Switzerland
-
Qianfoshan HospitalNot yet recruitingOpioid-Free Anaesthesia | Delirium - PostoperativeChina